Multiple endocrinopathies in an infant with fatal neurodegenerative disease

R R Shankar1, A Haider, W T Garvey

  • 1Department of Pediatrics, Indiana University, Indianapolis, USA.

Insights

This case study details a male infant with congenital hypoparathyroidism who developed multiple endocrine and neurologic disorders, including hypothyroidism and diabetes mellitus. The rare syndrome led to severe developmental delay and multiorgan failure, with an unidentified molecular cause.

Area of Science:

  • Endocrinology
  • Neurology
  • Genetics

Background:

  • Congenital hypoparathyroidism is a rare endocrine disorder.
  • Early-onset endocrine and neurologic dysfunction can present complex diagnostic challenges.

Observation:

  • A male infant presented with congenital hypoparathyroidism, followed by primary hypothyroidism and insulin-dependent diabetes mellitus.
  • Progressive neurologic deficits included severe developmental delay, blindness, deafness, seizures, and brain atrophy.
  • Multisystem involvement was observed, including renal hypoplasia, hyporeninemic hypoaldosteronism, anemia, elevated liver enzymes, cardiac conduction abnormalities, T-cell reduction, and facial anomalies.

Findings:

  • The patient exhibited a rare, severe syndrome with multiple endocrine and neurologic manifestations.
  • Widespread organ system involvement suggested a complex underlying etiology.
  • Despite clinical suspicion of a mitochondrial disorder, the specific molecular mechanism remains unidentified.

Implications:

  • This case highlights a severe, likely genetic, syndrome with a broad impact on multiple organ systems.
  • Further research is needed to elucidate the molecular basis of this rare condition.
  • Understanding such syndromes is crucial for early diagnosis and potential therapeutic strategies.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...